Exact Mass: 580.3975

Exact Mass Matches: 580.3975

Found 32 metabolites which its exact mass value is equals to given mass value 580.3975, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

DG(10:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl decanoic acid

C33H56O8 (580.3975)


DG(10:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGE2/10:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl decanoic acid

C33H56O8 (580.3975)


DG(PGE2/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl decanoic acid

C33H56O8 (580.3975)


DG(10:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGE2/0:0/10:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl decanoic acid

C33H56O8 (580.3975)


DG(PGE2/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl decanoic acid

C33H56O8 (580.3975)


DG(10:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGD2/10:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl decanoic acid

C33H56O8 (580.3975)


DG(PGD2/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl decanoic acid

C33H56O8 (580.3975)


DG(10:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGD2/0:0/10:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl decanoic acid

C33H56O8 (580.3975)


DG(PGD2/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5S,6S,7E,9E,11Z,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C33H56O8 (580.3975)


DG(10:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/10:0/0:0)

(2S)-2-(decanoyloxy)-3-hydroxypropyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C33H56O8 (580.3975)


DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-3-(decanoyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C33H56O8 (580.3975)


DG(10:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C33H56O8 (580.3975)


DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

(22S)-cholest-5-ene-3beta,11beta,16beta,22-tetrol 16-O-alpha-L-rhamnopyranoside

(22S)-cholest-5-ene-3beta,11beta,16beta,22-tetrol 16-O-alpha-L-rhamnopyranoside

C33H56O8 (580.3975)


   

DG(10:0/PGE2/0:0)

DG(10:0/PGE2/0:0)

C33H56O8 (580.3975)


   

DG(PGE2/10:0/0:0)

DG(PGE2/10:0/0:0)

C33H56O8 (580.3975)


   

DG(10:0/0:0/PGE2)

DG(10:0/0:0/PGE2)

C33H56O8 (580.3975)


   

DG(PGE2/0:0/10:0)

DG(PGE2/0:0/10:0)

C33H56O8 (580.3975)


   

DG(10:0/PGD2/0:0)

DG(10:0/PGD2/0:0)

C33H56O8 (580.3975)


   

DG(PGD2/10:0/0:0)

DG(PGD2/10:0/0:0)

C33H56O8 (580.3975)


   

DG(10:0/0:0/PGD2)

DG(10:0/0:0/PGD2)

C33H56O8 (580.3975)


   

DG(PGD2/0:0/10:0)

DG(PGD2/0:0/10:0)

C33H56O8 (580.3975)


   

DG(10:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

DG(10:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C33H56O8 (580.3975)


   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/10:0/0:0)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/10:0/0:0)

C33H56O8 (580.3975)


   

DG(10:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

DG(10:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C33H56O8 (580.3975)


   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/10:0)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/10:0)

C33H56O8 (580.3975)


   

ST 27:0;O2;GlcA

ST 27:0;O2;GlcA

C33H56O8 (580.3975)


   

ST 27:1;O3;Hex

ST 27:1;O3;Hex

C33H56O8 (580.3975)


   

2-{[7,10-dihydroxy-1-(3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

2-{[7,10-dihydroxy-1-(3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

C33H56O8 (580.3975)


   

(2r,3r,4r,5r,6s)-2-{[(1r,2s,3as,3bs,7s,9ar,9bs,10s,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

(2r,3r,4r,5r,6s)-2-{[(1r,2s,3as,3bs,7s,9ar,9bs,10s,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

C33H56O8 (580.3975)


   

(2r,3r,4r,5r,6s)-2-{[(1r,2s,3as,3bs,7s,9ar,9bs,10r,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

(2r,3r,4r,5r,6s)-2-{[(1r,2s,3as,3bs,7s,9ar,9bs,10r,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

C33H56O8 (580.3975)


   

(2r,3r,4r,5r,6s)-2-{[(1s,2s,3as,3bs,7r,9ar,9bs,10r,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

(2r,3r,4r,5r,6s)-2-{[(1s,2s,3as,3bs,7r,9ar,9bs,10r,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

C33H56O8 (580.3975)


   

(2r,3r,4r,5r,6s)-2-{[(1s,2s,3as,3bs,7s,9ar,9bs,10r,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

(2r,3r,4r,5r,6s)-2-{[(1s,2s,3as,3bs,7s,9ar,9bs,10r,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-6-methyloxane-3,4,5-triol

C33H56O8 (580.3975)